| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.
|
Lancet Infect Dis
|
2011
|
3.04
|
|
2
|
Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.
|
Pharmacoepidemiol Drug Saf
|
2010
|
2.57
|
|
3
|
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection.
|
AIDS
|
2006
|
2.26
|
|
4
|
PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.
|
HIV Med
|
2009
|
2.16
|
|
5
|
Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
|
J Infect Dis
|
2011
|
2.13
|
|
6
|
Multicenter prospective study of the burden of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.
|
J Infect Dis
|
2007
|
1.99
|
|
7
|
Drug use in children: cohort study in three European countries.
|
BMJ
|
2008
|
1.91
|
|
8
|
Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics.
|
Pediatrics
|
2005
|
1.55
|
|
9
|
Nosocomial rotavirus infection in European countries: a review of the epidemiology, severity and economic burden of hospital-acquired rotavirus disease.
|
Pediatr Infect Dis J
|
2006
|
1.54
|
|
10
|
Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants.
|
AIDS
|
2009
|
1.49
|
|
11
|
Effects of nutritional rehabilitation on intestinal function and on CD4 cell number in children with HIV.
|
J Pediatr Gastroenterol Nutr
|
2002
|
1.43
|
|
12
|
Intussusception among young children in Europe.
|
Pediatr Infect Dis J
|
2006
|
1.42
|
|
13
|
Clinical manifestations and socio-economic impact of influenza among healthy children in the community.
|
J Infect
|
2011
|
1.40
|
|
14
|
Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
|
AIDS
|
2007
|
1.28
|
|
15
|
Impact of community-acquired paediatric rotavirus gastroenteritis on family life: data from the REVEAL study.
|
BMC Fam Pract
|
2010
|
1.24
|
|
16
|
Assessment of pediatric asthma drug use in three European countries; a TEDDY study.
|
Eur J Pediatr
|
2010
|
1.19
|
|
17
|
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.
|
BMC Infect Dis
|
2012
|
1.16
|
|
18
|
Five-year follow-up of children with perinatal HIV-1 infection receiving early highly active antiretroviral therapy.
|
BMC Infect Dis
|
2009
|
1.14
|
|
19
|
Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness.
|
AIDS
|
2002
|
1.14
|
|
20
|
Distribution of rotavirus genotypes in Europe, 2004-2005: the REVEAL Study.
|
J Infect Dis
|
2007
|
1.13
|
|
21
|
Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
|
Pediatr Infect Dis J
|
2003
|
1.13
|
|
22
|
Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response.
|
Antivir Ther
|
2008
|
1.13
|
|
23
|
Economics of rotavirus gastroenteritis and vaccination in Europe: what makes sense?
|
Pediatr Infect Dis J
|
2006
|
1.10
|
|
24
|
Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.
|
J Am Med Inform Assoc
|
2012
|
1.09
|
|
25
|
Defining off-label and unlicensed use of medicines for children: results of a Delphi survey.
|
Pharmacol Res
|
2008
|
1.08
|
|
26
|
Databases for pediatric medicine research in Europe--assessment and critical appraisal.
|
Pharmacoepidemiol Drug Saf
|
2008
|
1.07
|
|
27
|
Older children and adolescents surviving with vertically acquired HIV infection.
|
J Acquir Immune Defic Syndr
|
2002
|
1.07
|
|
28
|
EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
|
Stud Health Technol Inform
|
2011
|
1.06
|
|
29
|
Long-term decay of the HIV-1 reservoir in HIV-1-infected children treated with highly active antiretroviral therapy.
|
J Infect Dis
|
2006
|
1.05
|
|
30
|
Pregnancy and HIV infection: A european consensus on management.
|
AIDS
|
2002
|
1.04
|
|
31
|
Rotavirus types in Europe and their significance for vaccination.
|
Pediatr Infect Dis J
|
2006
|
1.01
|
|
32
|
Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009.
|
BMC Infect Dis
|
2011
|
0.99
|
|
33
|
Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1.
|
J Transl Med
|
2010
|
0.98
|
|
34
|
Clinical trials of rotavirus vaccines in Europe.
|
Pediatr Infect Dis J
|
2006
|
0.98
|
|
35
|
The prescribing of analgesics and non-steroidal anti-inflammatory drugs in paediatric primary care in the UK, Italy and the Netherlands.
|
Pharmacol Res
|
2010
|
0.98
|
|
36
|
Comparison of antiepileptic drug prescribing in children in three European countries.
|
Epilepsia
|
2009
|
0.97
|
|
37
|
Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents.
|
AIDS
|
2008
|
0.96
|
|
38
|
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary.
|
J Pediatr Gastroenterol Nutr
|
2008
|
0.96
|
|
39
|
Early highly active antiretroviral therapy enhances B-cell longevity: a 5 year follow up.
|
Pediatr Infect Dis J
|
2014
|
0.95
|
|
40
|
Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.
|
BMC Public Health
|
2011
|
0.95
|
|
41
|
The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women.
|
AIDS
|
2013
|
0.93
|
|
42
|
Idiopathic acute liver injury in paediatric outpatients: incidence and signal detection in two European countries.
|
Drug Saf
|
2013
|
0.93
|
|
43
|
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
|
PLoS One
|
2013
|
0.92
|
|
44
|
Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children.
|
AIDS
|
2012
|
0.92
|
|
45
|
A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA).
|
Arch Dis Child
|
2011
|
0.91
|
|
46
|
Innovative study design for paediatric clinical trials.
|
Eur J Clin Pharmacol
|
2011
|
0.90
|
|
47
|
Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants.
|
AIDS
|
2013
|
0.90
|
|
48
|
European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe.
|
J Pediatr Gastroenterol Nutr
|
2008
|
0.89
|
|
49
|
Immune reconstitution and vaccination outcome in HIV-1 infected children: present knowledge and future directions.
|
Hum Vaccin Immunother
|
2012
|
0.89
|
|
50
|
Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau.
|
BMC Infect Dis
|
2011
|
0.89
|
|
51
|
Role of beta-defensin-1 polymorphisms in mother-to-child transmission of HIV-1.
|
J Acquir Immune Defic Syndr
|
2009
|
0.89
|
|
52
|
Recommendations for rotavirus vaccination: A worldwide perspective.
|
Vaccine
|
2010
|
0.89
|
|
53
|
Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project.
|
Stud Health Technol Inform
|
2010
|
0.89
|
|
54
|
Varicella vaccination in Italy : an economic evaluation of different scenarios.
|
Pharmacoeconomics
|
2004
|
0.89
|
|
55
|
Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration.
|
J Antimicrob Chemother
|
2006
|
0.88
|
|
56
|
HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children.
|
PLoS One
|
2008
|
0.88
|
|
57
|
Cancer rates after year 2000 significantly decrease in children with perinatal HIV infection: a study by the Italian Register for HIV Infection in Children.
|
J Clin Oncol
|
2007
|
0.88
|
|
58
|
Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy.
|
Virol J
|
2010
|
0.87
|
|
59
|
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.
|
Stud Health Technol Inform
|
2009
|
0.87
|
|
60
|
The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection.
|
BMC Infect Dis
|
2014
|
0.87
|
|
61
|
European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014.
|
Pediatr Infect Dis J
|
2015
|
0.87
|
|
62
|
Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.
|
Drug Saf
|
2014
|
0.86
|
|
63
|
The incidence of varicella: correction of a common error.
|
Epidemiology
|
2003
|
0.86
|
|
64
|
Bayesian parameter estimates of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1.
|
Antimicrob Agents Chemother
|
2005
|
0.86
|
|
65
|
Rotavirus.
|
J Pediatr Gastroenterol Nutr
|
2008
|
0.86
|
|
66
|
Post-licensing safety of fosamprenavir in HIV-infected children in Europe.
|
Pharmacoepidemiol Drug Saf
|
2014
|
0.86
|
|
67
|
Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
|
Clin Infect Dis
|
2009
|
0.86
|
|
68
|
Burden of acute otitis media in primary care pediatrics in Italy: a secondary data analysis from the Pedianet database.
|
BMC Pediatr
|
2012
|
0.84
|
|
69
|
Efficacy and safety of darunavir/ritonavir at 48 weeks in treatment-naïve, HIV-1-infected adolescents: results from a phase 2 open-label trial (DIONE).
|
Pediatr Infect Dis J
|
2014
|
0.84
|
|
70
|
Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of age.
|
Br J Clin Pharmacol
|
2011
|
0.84
|
|
71
|
Current management of late onset neonatal bacterial sepsis in five European countries.
|
Eur J Pediatr
|
2014
|
0.84
|
|
72
|
The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence.
|
Paediatr Drugs
|
2009
|
0.83
|
|
73
|
Role of non-nucleoside reverse transcriptase inhibitors in treating HIV-infected children.
|
Drugs
|
2011
|
0.81
|
|
74
|
The role of genetic variants of Stromal cell-Derived Factor 1 in pediatric HIV-1 infection and disease progression.
|
PLoS One
|
2012
|
0.80
|
|
75
|
Update on antiretroviral therapy in paediatrics.
|
Antiviral Res
|
2009
|
0.80
|
|
76
|
Pharmacokinetics and short-term safety and tolerability of etravirine in treatment-experienced HIV-1-infected children and adolescents.
|
AIDS
|
2012
|
0.79
|
|
77
|
Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network.
|
Antivir Ther
|
2013
|
0.79
|
|
78
|
Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy.
|
AIDS
|
2005
|
0.78
|
|
79
|
Programmatic impact of the evolution of WHO pediatric antiretroviral treatment guidelines for resource-limited countries (Tukula Fenna Project, Uganda).
|
J Acquir Immune Defic Syndr
|
2012
|
0.78
|
|
80
|
Premature aging and immune senescence in HIV-infected children.
|
AIDS
|
2016
|
0.78
|
|
81
|
European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
|
J Int Bioethique
|
2008
|
0.78
|
|
82
|
Pharmacokinetics of pediatric lopinavir/ritonavir tablets in children when administered twice daily according to FDA weight bands.
|
Pediatr Infect Dis J
|
2014
|
0.78
|
|
83
|
Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience.
|
J Acquir Immune Defic Syndr
|
2016
|
0.77
|
|
84
|
A randomized controlled trial of genotypic HIV drug resistance testing in HIV-1-infected children: the PERA (PENTA 8) trial.
|
Antivir Ther
|
2006
|
0.76
|
|
85
|
Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa.
|
Expert Rev Vaccines
|
2015
|
0.76
|
|
86
|
Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®".
|
Vaccine
|
2010
|
0.75
|
|
87
|
Atazanavir exposure is effective during pregnancy regardless of tenofovir use.
|
Antivir Ther
|
2014
|
0.75
|
|
88
|
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
|
AIDS Behav
|
2013
|
0.75
|
|
89
|
Antiretroviral use in Italian children with perinatal HIV infection over a 14-year period.
|
Acta Paediatr
|
2012
|
0.75
|
|
90
|
Intrafamilial transmission of HIV-1.
|
AIDS
|
2003
|
0.75
|
|
91
|
Co-infection with HIV and HCV in 229 children and young adults living in Europe.
|
AIDS
|
2016
|
0.75
|
|
92
|
Using Prescription Patterns in Primary Care to Derive New Quality Indicators for Childhood Community Antibiotic Prescribing.
|
Pediatr Infect Dis J
|
2016
|
0.75
|
|
93
|
The Challenge of Treating Children with Hepatitis C Virus Infection.
|
J Pediatr Gastroenterol Nutr
|
2017
|
0.75
|
|
94
|
Risk of perinatal HIV infection in infants born in Italy to immigrant mothers.
|
Clin Infect Dis
|
2011
|
0.75
|